title: [Determination of the 120-day post prostatic biopsy mortality rate].
abstract: OBJECTIVE
  Concerning death-rates were reported following prostate biopsy but the lack of contexts in which event occurred makes it difficult to take any position. Therefore, we aimed to determine the 120-day post-biopsy mortality rate.
  
  
  METHODS
  Between 2000 and 2011, 8804 men underwent prostate biopsy in the hospice civils de Lyon. We studied retrospectively, the mortality rate after each of the 11,816 procedures. Biopsies imputability was assessed by examining all medical records. Dates of death were extracted from our local patient management database, which is updated trimestrially with death notifications from the French National Institute for Statistics and Economic Studies.
  
  
  RESULTS
  In our study 42 deaths occurred within 120days after 11,816 prostate biopsies (0.36%). Of the 42 records: 9 were lost to follow-up, 3 had no identifiable cause of death, 28 had an intercurrent event ruling out prostate biopsy as a cause of death. Only 2 deaths could be linked to biopsy.
  
  
  CONCLUSIONS
  We reported at most 2 deaths possibly related to prostate biopsy over 11,816 procedures (0.02%). We confirmed the fact that prostate biopsies can be lethal but this rare outcome should not be considered as an argument against prostate screening given the circumstances in which it occurs.
  
  
  METHODS
  5.
authors.affiliation: Hospices civils de Lyon, pôle information médicale évaluation recherche, site Lacassagne, bâtiment A, 162, avenue Lacassagne, 69424 Lyon cedex 03, France. Electronic address: guillaume-adrien.canat@chu-lyon.fr.
authors.forename: G A
authors.initials: GA
authors.lastname: Canat
authors.affiliation: Hospices civils de Lyon, pôle information médicale évaluation recherche, site Lacassagne, bâtiment A, 162, avenue Lacassagne, 69424 Lyon cedex 03, France. Electronic address: antoine.duclose@chu-lyon.fr.
authors.forename: A
authors.initials: A
authors.lastname: Duclos
authors.affiliation: Hospices civils de Lyon, pôle information médicale évaluation recherche, site Lacassagne, bâtiment A, 162, avenue Lacassagne, 69424 Lyon cedex 03, France. Electronic address: sandrine.couray-targe@chu-lyon.fr.
authors.forename: S
authors.initials: S
authors.lastname: Couray-Targe
authors.affiliation: Hospices civils de Lyon, pôle information médicale évaluation recherche, site Lacassagne, bâtiment A, 162, avenue Lacassagne, 69424 Lyon cedex 03, France. Electronic address: anne-marie.schott-petelaz@chu-lyon.fr.
authors.forename: A-M
authors.initials: AM
authors.lastname: Schott
authors.affiliation: Hospices civils de Lyon, pôle information médicale évaluation recherche, site Lacassagne, bâtiment A, 162, avenue Lacassagne, 69424 Lyon cedex 03, France. Electronic address: stephaine.polazzi@chu-lyon.fr.
authors.forename: S
authors.initials: S
authors.lastname: Polazzi
authors.affiliation: Service d'anatomopathologie, université de l'hôpital de Lyon Sud, hospices civils de Lyon, chemin du Grand-Revoyet, 69495 Pierre-Bénite, France.
authors.forename: J-Y
authors.initials: JY
authors.lastname: Scoazec
authors.affiliation: Service d'urologie, université de l'hôpital d'Édouard-Herriot, hospices civils de Lyon, 5, place d'Arsonval, 69003 Pierre-Bénite, France. Electronic address: francoise.berger@chu-lyon.fr.
authors.forename: F
authors.initials: F
authors.lastname: Berger
authors.affiliation: Service d'urologie, université de l'hôpital de Lyon Sud, hospices civils de Lyon, 5, place d'Arsonval, 69003 Pierre-Bénite, France. Electronic address: paul.perrin@chu-lyon.fr.
authors.forename: P
authors.initials: P
authors.lastname: Perrin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle / Q000401:mortality* / Q000706:statistics & numerical data; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology*; D012189:Retrospective Studies
keywords: Biopsie; Biopsy; Cancer; Cause of death; Causes; Death rate; Mort; Prostate